PTJ
CNMD icon

Paul Tudor Jones’s CONMED CNMD Stock Holding History

Paul Tudor Jones’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,800
Closed -$249K – 2479
2022
Q4 		$249K Buy
+2,800
New +$232K ﹤0.01% 2021

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Paul Tudor Jones's CNMD Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in CONMED (CNMD) in Q2 2026: 23,303 shares worth $763K. The stake represents ﹤0.01% of the portfolio and ranks #2598 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in CNMD as recently as Q4 2025.

Paul Tudor Jones first reported a position in CNMD in Q2 2013 and has held it in 29 quarters since. The position peaked at $9.08M in Q1 2024. 245 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Paul Tudor Jones held 23,303 shares of CONMED worth $763K as of Q2 2026.
  • CONMED was a new Paul Tudor Jones position in Q2 2026.
  • CONMED made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2598 holding.
  • Paul Tudor Jones first reported a position in CONMED in Q2 2013 and has held it in 29 quarters since.
  • Paul Tudor Jones's CONMED position peaked at $9.08M in Q1 2024.
  • 245 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.